Back to search

France· FR:67435682

NOMANESIT 85 mg/500 mg comprimé pelliculé

A medicinal product containing naproxène sodique + succinate de sumatriptan, registered in France by ORION CORPORATION, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNOMANESIT 85 mg/500 mg comprimé pelli…ATC—REGISTER NO.FR:67435682PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
NAPROXÈNE SODIQUE + SUCCINATE DE SUMATRIPTAN
Manufacturer
ORION CORPORATION
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930292433
    plaquette(s) PVC aluminium OPA : polyamide orienté de 9 comprimé(s)
    EUR 12.02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Naproxène sodique + succinate de sumatriptan in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naproxène sodique + succinate de sumatriptan products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Sumanet
  • Belgium · Migsun
  • Czechia · Frimig Duo
  • Germany · Suvexx
  • Denmark · Nomigrin
  • Estonia · Migsun
  • Spain · Suvexx
  • Finland · Nomigrin
  • United Kingdom (Northern Ireland) · Suvexx
  • Greece · Suvexx
  • Hungary · Nomigrin
  • Ireland · Migsun
  • Italy · Sumanet
  • Lithuania · Migsun
  • Latvia · Migsun
  • Netherlands · Suvexx
  • Norway · Nomigrin
  • Poland · Frimig Duo
  • Portugal · Suvexx
  • Sweden · Nomigrin
  • Slovakia · Frimig Duo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6635d9a5-aaa7-4c27-840a-fdcb1773215f
GET /v1/drugs/6635d9a5-aaa7-4c27-840a-fdcb1773215f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67435682",
  "date_amm": "2024-03-22",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "NAPROXÈNE SODIQUE + SUCCINATE DE SUMATRIPTAN",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about naproxène sodique + succinate de sumatriptan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.